NO864901L - Ekspresjon og diognostisk anvendelse av gag-kodet peptider som er immunologisk aktive med antistoffer mot lav. - Google Patents

Ekspresjon og diognostisk anvendelse av gag-kodet peptider som er immunologisk aktive med antistoffer mot lav.

Info

Publication number
NO864901L
NO864901L NO864901A NO864901A NO864901L NO 864901 L NO864901 L NO 864901L NO 864901 A NO864901 A NO 864901A NO 864901 A NO864901 A NO 864901A NO 864901 L NO864901 L NO 864901L
Authority
NO
Norway
Prior art keywords
expression
lav
proteins
qaq
gag
Prior art date
Application number
NO864901A
Other languages
English (en)
Norwegian (no)
Other versions
NO864901D0 (no
Inventor
Susan Mitsue Watanabe
Wesley Cosand
Susan Mcardle
Bruce Mcfarland Travis
Pamela June Ward
Original Assignee
Genetic Systems Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from PCT/US1986/000716 external-priority patent/WO1986006099A1/en
Application filed by Genetic Systems Corp filed Critical Genetic Systems Corp
Publication of NO864901D0 publication Critical patent/NO864901D0/no
Publication of NO864901L publication Critical patent/NO864901L/no

Links

Landscapes

  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Peptides Or Proteins (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
NO864901A 1985-04-08 1986-12-05 Ekspresjon og diognostisk anvendelse av gag-kodet peptider som er immunologisk aktive med antistoffer mot lav. NO864901L (no)

Applications Claiming Priority (5)

Application Number Priority Date Filing Date Title
US72123785A 1985-04-08 1985-04-08
US75376985A 1985-07-10 1985-07-10
US76346085A 1985-08-07 1985-08-07
US82882886A 1986-02-12 1986-02-12
PCT/US1986/000716 WO1986006099A1 (en) 1985-04-08 1986-04-07 EXPRESSION AND DIAGNOSTIC USE OF gag ENCODED PEPTIDES WHICH ARE IMMUNOLOGICALLY REACTIVE WITH ANTIBODIES TO LAV

Publications (2)

Publication Number Publication Date
NO864901D0 NO864901D0 (no) 1986-12-05
NO864901L true NO864901L (no) 1987-02-05

Family

ID=27536422

Family Applications (1)

Application Number Title Priority Date Filing Date
NO864901A NO864901L (no) 1985-04-08 1986-12-05 Ekspresjon og diognostisk anvendelse av gag-kodet peptider som er immunologisk aktive med antistoffer mot lav.

Country Status (2)

Country Link
DK (1) DK168892B1 (da)
NO (1) NO864901L (da)

Also Published As

Publication number Publication date
DK589586A (da) 1987-02-09
DK168892B1 (da) 1994-07-04
NO864901D0 (no) 1986-12-05
DK589586D0 (da) 1986-12-08

Similar Documents

Publication Publication Date Title
ES2009350A6 (es) Procedimiento para la preparacion de vectores de expresion que codifican una nueva proteina.
Ramsburg et al. Highly effective control of an AIDS virus challenge in macaques by using vesicular stomatitis virus and modified vaccinia virus Ankara vaccine vectors in a single-boost protocol
DK513388D0 (da) Peptider med immunologiske egenskaber svarende til hiv-2 virus, nucleotidsekvenser, der koder for saadanne peptider, antigene og immunogene midler indeholdende saadanne peptider samt fremgangsmaade og kit til in vitro diagnose af hiv-2
GR860915B (en) Expression and diagnostic use of gag encoded peptides which are immunologically reactive with antibodies to lav
NZ215867A (en) Aids envelope protein, dna vectors and method of production
DK284986A (da) Antigen og virus, fremgangsmaade til fremstilling af antigenet, anvendelse af antigener ved fremstilling af immunogene praeparater eller til diagnose af antistoffer mod viruset
ES8706208A1 (es) Un metodo para preparar proteinas que son inmunologicamente reactivas con anticuerpos para virus asociados con linfadenopatia
US4755380A (en) Peptide from amyloid A and antiserum therefor
FI885296A0 (fi) Rekombinant hiv-2 polypeptid.
Cohen et al. Soluble Antigens of Vaccinia-infected Mammalian Cells: III. Relation of “Early” and “Late” Proteins to Virus Structure
Schneider et al. Abnormal predominance of IgG in HIV-specific antibodies produced by short-term cultured duodenal biopsy specimens from HIV-infected patients
DK589586A (da) Ekspression og diagnostisk anvendelse af gag-kodede peptider, der er immunologisk reaktive med antistoffer til lav.
Arrode-Brusés et al. Characterization of T-cell responses in macaques immunized with a single dose of HIV DNA vaccine
Denner et al. Suppression of human lymphocyte mitogen response by proteins of the type‐D retrovirus PMFV
Craft Pathogenic and antigenic diversity in Infectious bursal disease viruses.
Izumi et al. Intravenous Inoculation of Replication-DeficientRecombinant Vaccinia Virus DIs Expressing Simian ImmunodeficiencyVirus Gag Controls Highly Pathogenic Simian-HumanImmunodeficiency Virus inMonkeys
WO2011075806A2 (pt) Vacina para lentivirus baseada no vírus recombinante vacinal da febre amarela
Stirtzinger Experimental bovine leukemia virus infection in sheep: host response and control by vaccination.
Coleman POLYPEPTIDE CHANGES IN L-CELL PLASMA MEMBRANES AFTER REOVIRUS INFECTION.
Parekh Equine infectious anemia virus: characterization of virion polypeptides and the biochemical nature of antigenic variation.
PT90800A (pt) Processo para a preparacao de antigenios precursores das glicoproteinas de involucro de um retrovirus humano hiv-2 e de antigenios que apresentem uma analogia imonulogiga com estes ultimos e sua aplicacao ao diagnostico
FR2227862A1 (en) Non-arthrogenic immunological adjuvants - obtained by extraction of lipid-free mycobacterial residues
ES2155436T3 (es) Proteinas recombinantes con la reactividad inmunologica del antigeno e del virus de la hepatitis b (hbeag), procedimiento para su preparacion y su utilizacion en analisis inmunologicos y en vacunas.